
Effect of Visit‐to‐Visit Variation of Heart Rate and Systolic Blood Pressure on Outcomes in Chronic Systolic Heart Failure: Results From the Systolic Heart Failure Treatment With the I f Inhibitor Ivabradine Trial ( SHIFT ) Trial
Author(s) -
Böhm Michael,
Robertson Michele,
Borer Jeffrey,
Ford Ian,
Komajda Michel,
Mahfoud Felix,
Ewen Sebastian,
Swedberg Karl,
Tavazzi Luigi
Publication year - 2016
Publication title -
journal of the american heart association
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.494
H-Index - 85
ISSN - 2047-9980
DOI - 10.1161/jaha.115.002160
Subject(s) - medicine , heart failure , ivabradine , blood pressure , cardiology , clinical endpoint , heart rate , coefficient of variation , hazard ratio , confidence interval , clinical trial , statistics , mathematics
Elevated resting heart rate (HR) and low systolic blood pressure (SBP) are related to poor outcomes in heart failure (HF). The association between visit-to-visit variation in SBP and HR and risk in HF is unknown.